Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[SRD5A2 and HSD3B2 polymorphisms are associated with prostate cancer risk and aggressiveness.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP18522.RA4zyNshrSWgX6Kuw-40jBrpHx9jVxIv6qFx8b3hJTciY130_assertion description "[SRD5A2 and HSD3B2 polymorphisms are associated with prostate cancer risk and aggressiveness.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP18522.RA4zyNshrSWgX6Kuw-40jBrpHx9jVxIv6qFx8b3hJTciY130_provenance.
• NP30895.RAOx6FdkfRbCcfmXYL-KXkXkcB-YFLxYFEUji-J8Q8OJ4130_assertion description "[SRD5A2 and HSD3B2 polymorphisms are associated with prostate cancer risk and aggressiveness.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP30895.RAOx6FdkfRbCcfmXYL-KXkXkcB-YFLxYFEUji-J8Q8OJ4130_provenance.
• NP867157.RAuZZoiNaJ4VwgtYpbUbYleMGJKwzMTL9i3FeWzT_fE6U130_assertion description "[SRD5A2 and HSD3B2 polymorphisms are associated with prostate cancer risk and aggressiveness.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP867157.RAuZZoiNaJ4VwgtYpbUbYleMGJKwzMTL9i3FeWzT_fE6U130_provenance.
• NP17711.RA2b55IQoGU8hBqyl3bVAffsz3ty8EXSRXSmwMcM9vjXw130_assertion description "[SRD5A2 and HSD3B2 polymorphisms are associated with prostate cancer risk and aggressiveness.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP17711.RA2b55IQoGU8hBqyl3bVAffsz3ty8EXSRXSmwMcM9vjXw130_provenance.
• assertion description "[SRD5A2 and HSD3B2 polymorphisms are associated with prostate cancer risk and aggressiveness.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[SRD5A2 and HSD3B2 polymorphisms are associated with prostate cancer risk and aggressiveness.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[SRD5A2 and HSD3B2 polymorphisms are associated with prostate cancer risk and aggressiveness.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[SRD5A2 and HSD3B2 polymorphisms are associated with prostate cancer risk and aggressiveness.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[SRD5A2 and HSD3B2 polymorphisms are associated with prostate cancer risk and aggressiveness.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[SRD5A2 and HSD3B2 polymorphisms are associated with prostate cancer risk and aggressiveness.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[SRD5A2 and HSD3B2 polymorphisms are associated with prostate cancer risk and aggressiveness.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[SRD5A2 and HSD3B2 polymorphisms are associated with prostate cancer risk and aggressiveness.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP465845.RApwOvqQavtzer9TOxUoOCPlDerH1m3DBdRGEwdezUmj8130_assertion description "[SRD5A2 and HSD3B2 polymorphisms are associated with prostate cancer risk and aggressiveness.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP465845.RApwOvqQavtzer9TOxUoOCPlDerH1m3DBdRGEwdezUmj8130_provenance.
• NP628955.RAXV9D0z6cLVWJQms5UUoEt2QHScawtS4XMuOVBUCG5YE130_assertion description "[SRD5A2 and HSD3B2 polymorphisms are associated with prostate cancer risk and aggressiveness.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP628955.RAXV9D0z6cLVWJQms5UUoEt2QHScawtS4XMuOVBUCG5YE130_provenance.
• NP628956.RAWmv-caTFxCOZ4EVypuj4_ZqyVRJ1ad7n0k78kPysyB4130_assertion description "[SRD5A2 and HSD3B2 polymorphisms are associated with prostate cancer risk and aggressiveness.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP628956.RAWmv-caTFxCOZ4EVypuj4_ZqyVRJ1ad7n0k78kPysyB4130_provenance.
• NP31172.RAHDji42e1N-_0etqlgx2DVIVguMWFJXvGywPePdwQoq0130_assertion description "[SRD5A2 and HSD3B2 polymorphisms are associated with prostate cancer risk and aggressiveness.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP31172.RAHDji42e1N-_0etqlgx2DVIVguMWFJXvGywPePdwQoq0130_provenance.
• NP73466.RA-5HHSl1vIWbeigkeWXnXc740GChJx80tjAmcrQ1UlOQ130_assertion description "[SRD5A2 and HSD3B2 polymorphisms are associated with prostate cancer risk and aggressiveness.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP73466.RA-5HHSl1vIWbeigkeWXnXc740GChJx80tjAmcrQ1UlOQ130_provenance.
• NP465851.RA1wUaRJyUVazFyW4sXpE2wTlxJTFmHeWRTNZDGEEPQcA130_assertion description "[SRD5A2 and HSD3B2 polymorphisms are associated with prostate cancer risk and aggressiveness.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP465851.RA1wUaRJyUVazFyW4sXpE2wTlxJTFmHeWRTNZDGEEPQcA130_provenance.
• NP20484.RAJXLfJpwrowC1J6NczJVJcL16LEQL05cBsh7WX6jiv-g130_assertion description "[SRD5A2 and HSD3B2 polymorphisms are associated with prostate cancer risk and aggressiveness.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP20484.RAJXLfJpwrowC1J6NczJVJcL16LEQL05cBsh7WX6jiv-g130_provenance.
• NP20485.RAHbNuSsRd8PD_pPvtQck_U2_nNQzkvc0DAEZePkm-YDI130_assertion description "[SRD5A2 and HSD3B2 polymorphisms are associated with prostate cancer risk and aggressiveness.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP20485.RAHbNuSsRd8PD_pPvtQck_U2_nNQzkvc0DAEZePkm-YDI130_provenance.
• NP111473.RAKc9VRfhFsmzST9eljKurvYRUH39FdulJ2wEVBZe9VRQ130_assertion description "[SRD5A2 and HSD3B2 polymorphisms are associated with prostate cancer risk and aggressiveness.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP111473.RAKc9VRfhFsmzST9eljKurvYRUH39FdulJ2wEVBZe9VRQ130_provenance.
• NP628957.RAJTTkqk-I3uZWaWGWhGIeBzE9fV3az7HhiUf6jMV2nlo130_assertion description "[SRD5A2 and HSD3B2 polymorphisms are associated with prostate cancer risk and aggressiveness.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP628957.RAJTTkqk-I3uZWaWGWhGIeBzE9fV3az7HhiUf6jMV2nlo130_provenance.
• NP628958.RALG-Xlmm5owfC9nuC-xtTEIrQtZcI6VDqleaMTu24q28130_assertion description "[SRD5A2 and HSD3B2 polymorphisms are associated with prostate cancer risk and aggressiveness.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP628958.RALG-Xlmm5owfC9nuC-xtTEIrQtZcI6VDqleaMTu24q28130_provenance.
• NP111472.RA5MKKCkj8NZtFysNx9act0SxsCJT2naCf8VD7e7VOOFc130_assertion description "[SRD5A2 and HSD3B2 polymorphisms are associated with prostate cancer risk and aggressiveness.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP111472.RA5MKKCkj8NZtFysNx9act0SxsCJT2naCf8VD7e7VOOFc130_provenance.